Format

Send to:

Choose Destination
See comment in PubMed Commons below
Rehabil Psychol. 2010 Aug;55(3):255-62. doi: 10.1037/a0020492.

Comorbid anxiety disorders and treatment of depression in people with multiple sclerosis.

Author information

  • 1Department of Preventive Medicine, Northwestern University, Feinberg School of Medicine, 680 N. Lake Shore Drive, Suite 1220, Chicago, IL 60611, USA. mcobb03@yahoo.com

Abstract

OBJECTIVE:

Anxiety is highly comorbid with depression, but little is known about the impact of anxiety disorders on the effectiveness of empirically supported psychotherapies for depression. We examined such outcomes for people with Multiple Sclerosis (MS) and depression, with versus without comorbid anxiety disorders.

DESIGN:

Participants with MS (N = 102) received 16 weeks of telephone-administered psychotherapy for depression and were followed for one year post-treatment.

RESULTS:

Participants with comorbid anxiety disorders improved to a similar degree during treatment as those without anxiety disorders. Outcomes during follow-up were mixed, and thus we divided the anxiety diagnoses into distress and fear disorders. The distress disorder (GAD) was associated with elevated anxiety symptoms during and after treatment. In contrast, fear disorders (i.e., panic disorder, agoraphobia, social phobia, specific phobia) were linked to depression, specifically during follow-up, across 3 different measures.

CONCLUSIONS:

People with GAD receiving treatment for depression may benefit from additional services targeting anxiety more specifically, while those with comorbid fear disorders may benefit from services targeting maintenance of gains after treatment.

PMID:
20804269
[PubMed - indexed for MEDLINE]
PMCID:
PMC2987627
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for American Psychological Association Icon for PubMed Central
    Loading ...
    Write to the Help Desk